Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Epidemiological Trends and Projections of PM2.5-Attributable COPD Burden in China Over 1990-2035
Miaoqian Li1,2,3, Liangjia Wang2,3, Abebe Feyissa Amhare3,4
1Department of Psychiatry, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Objective:
This study investigated long-term trends in the burden of chronic obstructive pulmonary disease (COPD) attributable to PM2.5 in China from 1990 to 2021 and projected future patterns through 2035.
Methods:
Data were obtained from the Global Burden of Disease Study 2021. Key indicators included disability-adjusted life years (DALYs), deaths, age-standardized disability-adjusted life years rates (ASDR), and age-standardized mortality rates (ASMR), which together characterize both individual-level and population-level disease burden. Analyses were stratified by sex and age group. Future trends were projected using a Bayesian age-period-cohort (BAPC) model.
Results:
From 1990 to 2021, the COPD burden in China showed a sustained downward trend. The overall ASDR decreased from 2692.65 to 473.09 per 100,000 population (approximately an 82.4% reduction), while the ASMR declined from 162.33 to 28.22 per 100,000 population (approximately an 82.6% reduction). More pronounced declines were observed during the mid-1990s to early 2000s. A modest increase in PM2.5-attributable COPD burden was noted in 2020, which may be associated with disruptions related to the COVID-19 pandemic. In 2021, COPD attributable to PM2.5 accounted for an estimated 9.16 million DALYs and 497,000 deaths, with a consistently higher burden observed among males. Projections indicate a continued overall decline in COPD burden by 2035, although a slight upward trend in ASMR is projected among males.
Conclusion:
COPD attributable to PM2.5 continues to impose a substantial public health burden in China. Despite long-term declines in age-standardized rates, the observed fluctuation in 2020 suggests ongoing vulnerability among individuals with chronic respiratory diseases. Continued efforts targeting air quality improvement and smoking reduction may contribute to further mitigation of COPD burden, particularly among high-risk populations.
More Related Videos
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
05:18Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History